arrow_back Back to App

US-Israel Collaboration to Accelerate Medical Technology and Drug Development.

This Act establishes a program to enhance cooperation between the United States and Israel in the research, development, and manufacturing of innovative medical products, including biological drugs and devices. The goal is to accelerate citizens' access to new, life-saving therapies, reduce production costs, and strengthen the security of essential health product supplies. The program also focuses on regulatory harmonization and telemedicine development.
Key points
Accelerating research on new drugs, vaccines, and medical devices through joint US-Israel research projects.
Supporting the manufacturing of biological products in the US to potentially lower costs and increase supply chain resilience.
Developing telemedicine and digital health solutions, which may improve access to medical care.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_8299
Sponsor: Rep. Buchanan, Vern [R-FL-16]
Process start date: 2024-05-08
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

MIRACLE Medical Technology Act of 2024

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_8299.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-05-08.

What are the main provisions?

Key points include:

  • Accelerating research on new drugs, vaccines, and medical devices through joint US-Israel research projects.
  • Supporting the manufacturing of biological products in the US to potentially lower costs and increase supply chain resilience.
  • Developing telemedicine and digital health solutions, which may improve access to medical care.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Buchanan, Vern [R-FL-16].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health Economy